Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ichiro Hanamura

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 8, 2020
[Emergence of Howell-Jolly bodies in a patient with splenic hypoplasia complicated by fulminant pneumococcal infection]Kaori Uchino, Fuminori Ato, Saki Yamada, et al.
Cancer Science|March 17, 2020
Biallelic loss of FAM46C triggers tumor growth with concomitant activation of Akt signaling in multiple myeloma cellsJo Kanasugi, Ichiro Hanamura, Akinobu Ota, et al.
Cell Death Discovery|December 10, 2020
Identification of CD24 as a potential diagnostic and therapeutic target for malignant pleural mesotheliomaSivasundaram Karnan, Akinobu Ota, Hideki Murakami, et al.
Cancer Science|June 26, 2003
Frequent occurrence of CCND1 deregulation in patients with early stages of plasma cell dyscrasiaKazuhisa Miura, Shinsuke Iida, Ichiro Hanamura, et al.
Ejhaem|July 18, 2022
Favorable prognostic phenotype in myelodysplastic syndrome with der(1;7)(q10;p10)Tomohiro Horio, Megumi Enomoto, Masaya Watarai, et al.
Annals of Hematology|April 6, 2016
Reduced frequency treatment with bortezomib plus dexamethasone for elderly patients with relapsed and/or refractory multiple myeloma: a phase 2 study of the Japanese Myeloma Study Group (JMSG-0902)Shuji Ozaki, Hiroyuki Hata, Masahiro Abe, et al.
Transplant Immunology|May 11, 2017
The recipient CCR5 variation predicts survival outcomes after bone marrow transplantationTomohiro Horio, Shohei Mizuno, Kaori Uchino, et al.
Leukemia & Lymphoma|September 24, 2010
Energy metabolism of leukemia cells: glycolysis versus oxidative phosphorylationKazuto Suganuma, Hiroshi Miwa, Norikazu Imai, et al.
Cancers|February 16, 2020
Donor Heme Oxygenase-1 Promoter Gene Polymorphism Predicts Survival after Unrelated Bone Marrow Transplantation for High-Risk PatientsTomohiro Horio, Eriko Morishita, Shohei Mizuno, et al.
Cancer Research|August 8, 2012
Frequent PVT1 rearrangement and novel chimeric genes PVT1-NBEA and PVT1-WWOX occur in multiple myeloma with 8q24 abnormalityHisao Nagoshi, Tomohiko Taki, Ichiro Hanamura, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 8, 2020
[Emergence of Howell-Jolly bodies in a patient with splenic hypoplasia complicated by fulminant pneumococcal infection]Kaori Uchino, Fuminori Ato, Saki Yamada, et al.
Cancer Science|March 17, 2020
Biallelic loss of FAM46C triggers tumor growth with concomitant activation of Akt signaling in multiple myeloma cellsJo Kanasugi, Ichiro Hanamura, Akinobu Ota, et al.
Cell Death Discovery|December 10, 2020
Identification of CD24 as a potential diagnostic and therapeutic target for malignant pleural mesotheliomaSivasundaram Karnan, Akinobu Ota, Hideki Murakami, et al.
Cancer Science|June 26, 2003
Frequent occurrence of CCND1 deregulation in patients with early stages of plasma cell dyscrasiaKazuhisa Miura, Shinsuke Iida, Ichiro Hanamura, et al.
Ejhaem|July 18, 2022
Favorable prognostic phenotype in myelodysplastic syndrome with der(1;7)(q10;p10)Tomohiro Horio, Megumi Enomoto, Masaya Watarai, et al.
Annals of Hematology|April 6, 2016
Reduced frequency treatment with bortezomib plus dexamethasone for elderly patients with relapsed and/or refractory multiple myeloma: a phase 2 study of the Japanese Myeloma Study Group (JMSG-0902)Shuji Ozaki, Hiroyuki Hata, Masahiro Abe, et al.
Transplant Immunology|May 11, 2017
The recipient CCR5 variation predicts survival outcomes after bone marrow transplantationTomohiro Horio, Shohei Mizuno, Kaori Uchino, et al.
Leukemia & Lymphoma|September 24, 2010
Energy metabolism of leukemia cells: glycolysis versus oxidative phosphorylationKazuto Suganuma, Hiroshi Miwa, Norikazu Imai, et al.
Cancers|February 16, 2020
Donor Heme Oxygenase-1 Promoter Gene Polymorphism Predicts Survival after Unrelated Bone Marrow Transplantation for High-Risk PatientsTomohiro Horio, Eriko Morishita, Shohei Mizuno, et al.
Cancer Research|August 8, 2012
Frequent PVT1 rearrangement and novel chimeric genes PVT1-NBEA and PVT1-WWOX occur in multiple myeloma with 8q24 abnormalityHisao Nagoshi, Tomohiko Taki, Ichiro Hanamura, et al.
Pageof 9